PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.68%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.68%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
4.91%
Dividend growth above 1.5x 1097.HK's 0.79%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
0.00%
OCF growth at 75-90% of 1097.HK's 0.00%. Bill Ackman would demand better working capital management or cost discipline.
0.00%
FCF growth 75-90% of 1097.HK's 0.00%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
No Data
No Data available this quarter, please select a different quarter.
158.15%
5Y CAGR of 158.15% while 1097.HK is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-16.88%
Negative 3Y CAGR while 1097.HK stands at 29.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
317.78%
OCF/share CAGR of 317.78% while 1097.HK is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
4104.26%
3Y OCF/share CAGR above 1.5x 1097.HK's 11.59%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
1260.73%
Net income/share CAGR of 1260.73% while 1097.HK is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
190.87%
3Y net income/share CAGR above 1.5x 1097.HK's 93.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
120.34%
Dividend/share CAGR of 120.34% while 1097.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.